US EPA confirms risks of brominated flame retardants (Unbekannt)
In:
Chemical & Engineering News
;
100
, 24
;
17
;
2022
-
ISSN:
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:US EPA confirms risks of brominated flame retardants
-
Weitere Titelangaben:C&EN
-
Erschienen in:Chemical & Engineering News ; 100, 24 ; 17
-
Verlag:
- Neue Suche nach: American Chemical Society
-
Erscheinungsort:Washington, DC
-
Erscheinungsdatum:04.07.2022
-
ISSN:
-
Coden:
-
DOI:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Unbekannt
-
Schlagwörter:
-
Datenquelle:
Inhaltsverzeichnis – Band 100, Ausgabe 24
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
Table of Contents| 2022
- 4
-
Gender equity at risk| 2022
- 5
-
Reactions| 2022
- 6
-
Nickel catalyst enables versatile amine synthesis| 2022
- 7
-
Graphene oxide auto-cross-links| 2022
- 8
-
Graphene device monitors blood pressure| 2022
- 8
-
New clues about how Mars formed| 2022
- 9
-
Single catalyst molecules tracked in solution| 2022
- 10
-
A single sheet of bonded buckyballs| 2022
- 10
-
Videos show bonds in short-lived metal clusters| 2022
- 10
-
Fluorine-studded nanohoops| 2022
- 11
-
Tata and LG Chem advance carbon capture and utilization| 2022
- 11
-
Albemarle to expand US lithium capacity| 2022
- 13
-
Croda lands US funding for Pennsylvania lipids plant| 2022
- 13
-
Drug firms invest in malaria and neglected tropical diseases| 2022
- 14
-
PTT to build US recycling plant| 2022
- 14
-
Neste will expand renewable products| 2022
- 14
-
Stellantis invests in lithium producer| 2022
- 14
-
Avantium strikes PEF offtake deals| 2022
- 14
-
Germany steps closer to rationing natural gas| 2022
- 14
-
Electric Hydrogen gets electrolysis funds| 2022
- 14
-
Chemical makers eye carbon capture in China| 2022
- 15
-
Targeted protein drug firms advance| 2022
- 15
-
Vitamin E maker Kensing acquires Vitae| 2022
- 15
-
Wacker to boost biotech R&D in Munich| 2022
- 15
-
Ipsen will acquire biotech firm Epizyme| 2022
- 15
-
Business Roundup| 2022
- 15
-
Astellas to pay Sutro $90 million for ADCs| 2022
- 17
-
US EPA confirms risks of brominated flame retardants| 2022
- 17
-
EPA to industry: Submit data up front| 2022
- 17
-
Hiring checklists help but don’t solve biases| 2022
- 17
-
Melamine targeted for possible EU regulation| 2022
- 18
-
How to define PFAS| 2022
- 20
-
What’s that stuff? Health-monitoring cat litter| 2022
- 23
-
Career Ladder: Michael Mullowney| 2022
- 24
-
Looking for a summer listen?| 2022
- 27
-
The winding path out of the lab| 2022
- 28
-
From a shark to a possible Parkinson’s drug| 2022
- 30
-
Bringing an orphan drug to market| 2022
- 32
-
Setting up to deliver a therapy for ALS| 2022
- 34
-
Classifieds| 2022
- 34
-
Masthead| 2022
- 34
-
Units, keep away from unwritten rules| 2022
- 34
-
Ads| 2022
- 35
-
ACS launches 2 new applied materials journals| 2022
- 35
-
Actions from the May ACS Board of Directors meeting| 2022
- 35
-
ACS announces 2 National Historic Chemical Landmark designations| 2022
- 35
-
ACS conference in Qatar strengthens regional research community| 2022
- 36
-
Call for papers: Midwest Regional Meeting| 2022
- 36
-
Call for papers: Northeast Regional Meeting| 2022
- 36
-
ACS Publications commits hybrid journals to open access Plan S| 2022
- 36
-
Call for papers: Western Regional Meeting| 2022
- 37
-
Call for papers: Southwest Regional Meeting| 2022
- 37
-
ACS congratulates NSF Graduate Research Fellowship awardees| 2022
- 40
-
Ways to add a splash of color to your summer| 2022